Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
about
Deletion of IL-33R attenuates VEGF expression and enhances necrosis in mammary carcinoma.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?Biology and relevance of human acute myeloid leukemia stem cells.Stem and progenitor cell alterations in myelodysplastic syndromes.Leukemic stem cells: identification and clinical application.GATA Factor-Dependent Positive-Feedback Circuit in Acute Myeloid Leukemia Cells.Transgenic expression of human cytokines in immunodeficient mice does not facilitate myeloid expansion of BCR-ABL1 transduced human cord blood cells.Interleukin 4 induces apoptosis of acute myeloid leukemia cells in a Stat6-dependent manner.Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells.The family of the interleukin-1 receptors.Research of differential expression of sIL1RAP in low-grade gliomas between children and adults.SRSF10-mediated IL1RAP alternative splicing regulates cervical cancer oncogenesis via mIL1RAP-NF-κB-CD47 axis.Targeting Leukemia Stem Cells in the Bone Marrow Niche.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2.Eleutheroside B1 mediates its anti-influenza activity through POLR2A and N-glycosylation
P2860
Q37109698-D6630975-2B73-48E6-A3A6-2E1C5673CC3CQ38700209-EAF00AE0-68D9-4C49-BAFB-08C8445ED6B7Q38761783-AD6B4C3F-DA74-4916-9A1D-7478A24F1EBEQ38761791-E095F869-57F0-4C3D-8331-CE90CF7E34DAQ39208298-E874B298-9114-43F6-B1E0-B32231AFA83DQ42353379-87AF0C3C-9450-4045-94FA-6EFAD42BA51CQ42375720-F37AA6C6-0498-48DF-B8B7-E663A13459DBQ45870922-FEA96CB4-74EE-4ECC-A81E-038C308AE9D7Q47116205-A4E29C8F-AEA9-4CCB-9EA8-DC1BBF6201D9Q47285858-79F39F40-6A23-49C2-9EC5-3CAABCA8E111Q47916938-78E25E05-3F8B-46D2-B40E-30BF25FAA5BEQ50074498-ABFBA0BE-65CB-4DF9-966E-891DB8B88D59Q52375473-1E29EE3B-A105-44A0-9BA0-1EB02FE9B6C4Q55354182-25092A36-0A25-42C5-B621-5C25B17648C7Q55397325-7B9A80C3-E0B2-48AE-AC2E-2D109A52E29EQ58758066-8E4F2B81-678C-4E17-B5E2-9B05196AEA38
P2860
Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@ast
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@en
type
label
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@ast
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@en
prefLabel
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@ast
Antibodies targeting human IL1 ...... els of acute myeloid leukemia.
@en
P2093
P2860
P356
P1476
Antibodies targeting human IL1 ...... dels of acute myeloid leukemia
@en
P2093
Carl Högberg
Carl Sandén
Christine Karlsson
Gunnar Juliusson
Helena Ågerstam
James C Mulloy
Johan Richter
Kjell Sjöström
Maria Askmyr
Marianne Rissler
P2860
P304
10786-10791
P356
10.1073/PNAS.1422749112
P407
P577
2015-08-10T00:00:00Z